Fresenius stock steadies near 47 euro after Q2 beat
Published on 08/13/2026 at 14:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Fresenius stock (ISIN DE0005785604) held near 47 euro on Xetra after stronger second-quarter results and a higher 2026 outlook, with the latest close at 47.15 euro on August 12, 2026.
The shares ended the most recent session with a 1.16 percent five-day gain and a 3.99 percent year-to-date decline, while the average published target of 55.44 euro implies a 17.6 percent gap to the last close.
Why the move matters
The fresh read-through is not just the market move. The company said second-quarter operating performance came in ahead of prior assumptions and paired that with higher full-year 2026 objectives, which gives the share price a clearer earnings anchor.
That matters because the stock still trades below the average target and well below the level implied by a re-rating toward the revised outlook. The spread between 47.15 euro and 55.44 euro is the number investors will keep watching.
Current trading picture
The most recent market snapshot shows a real-time quote of 47.48 euro at 10:30:16 a.m. ET on August 13, 2026, after a previous close of 47.15 euro. Market data in the same snapshot put the one-year move at minus 3.99 percent.
The company also carries a market capitalization of 12.74 billion dollars in the cited market snapshot, with a 52-week range of 20.02 to 27.64 dollars shown for the U.S.-listed peer data that appeared in the same results set.
Report context
Second-quarter results and the updated 2026 guidance are the main fundamental reference point in the material surfaced for this session. The latest available overview ties the stronger quarter to better-than-expected operating performance and a sharper earnings path for the rest of 2026.
In practical terms, that keeps focus on whether the company can keep converting the second-quarter beat into a steadier margin profile across the next reporting periods. A first.
Business backdrop
Fresenius SE & Co. KGaA is a diversified healthcare group with hospital operations, medical services, and related products that support recurring demand across its portfolio. The mix gives investors a way to track execution through both volumes and margins rather than a single product cycle.
Price and valuation
On Xetra, Fresenius stock was last quoted at 47.48 euro at 10:30:16 a.m. ET on August 13, 2026, after closing at 47.15 euro in the prior session. The valuation gap to the 55.44 euro average target remains the cleanest quantified benchmark in the current market picture.
Fresenius stock at a glance
Company: Fresenius SE & Co. KGaA
ISIN: DE0005785604
Ticker: FRE
Exchange: Xetra
Price (as of August 13, 2026, 10:30:16 a.m. ET): EUR 47.48
Market cap: EUR 12.74 billion
Sector / Industry: Health care / providers and services
Index membership: DAX
